Compare Novavax Inc (NVAX) vs Pure Storage (P) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Pure Storage — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while Pure Storage trades at $154.49 (market cap $50.17B). The key difference: Pure Storage is far larger — about 27.6× Novavax Inc's market cap, and Novavax Inc is more actively traded (6,198,505 versus 5,733,762). Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and Pure Storage for 3 Days on average.
| NVAX | P | |
|---|---|---|
Market Cap | $1.82B | $50.17B |
Volume | 6,198,505 | 5,733,762 |
Sector | Health | Technology |
52-Week High | $12.75 | $152.84 |
52-Week Low | $6.22 | $56.99 |
Typical Hold Time | 59 Days | 3 Days |
Enterprise Value | $1.39B | $49.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Pure Storage
Pure Storage develops enterprise data storage and data management systems, primarily using all-flash technology. Its platform supports cloud, AI, analytics, and mission-critical application workloads.
Read more on P →
